Xcout IntelHealome Therapeutics
Healome Therapeutics is an eye care therapeutics company headquartered in Birmingham, United Kingdom. The company focuses on developing more effective, safer, and practical treatments for vision-threatening ocular surface diseases.
Subscribe to see Healome Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Healome Therapeutics at a glance
Healome Therapeutics is a healthcare company headquartered in United Kingdom, founded in 2021. Its most recent funding round, Seed, raised $2.6M in July 2026. Xcout tracks 4 named people at Healome Therapeutics, including Richard Williams (Co-Founder and CEO).
Healome Therapeutics leadership
- Richard WilliamsCo-Founder and CEO
- Liam GroverCo-Founder
- Richard MoakesCo-Founder
- Tony MetcalfeCo-Founder
Healome Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $2.6M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Healome Therapeutics news
Investors
Healome Therapeutics competitors
A few of Healome Therapeutics's closest competitors — see the full list of competitors and alternatives →
Vantage Biosciences is a clinical-stage biotechnology company headquartered in London, United Kingdom. Founded in 2023, the firm focuses primarily on advancements and clinical trials in the field of ophthalmology. It manages drug pipelines and pharmaceutical research out of its London office.
SolasCure Limited is a biotechnology research company registered and headquartered in Cambridge, United Kingdom, focused on developing novel wound care solutions.
Breye Therapeutics ApS is a biotechnology company committed to closing the gap in eye care by developing first-in-class oral small molecule therapies to treat retinal diseases. The company is advancing oral therapies like danegaptide for the early treatment of these conditions.
Prokarium is a biotechnology research company headquartered in London, United Kingdom, focused on developing targeted immunotherapies like its investigational treatment ZH9.
Get Healome Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Healome Therapeutics in Xcout Intel
- 4 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access